WILMINGTON — Inclinix, a contract research organization that focuses on enrollment for clinical trials, has added several executives to its management team.
Steven Agnoff is now vice president of marketing and product management. He had worked previously at PDI, PharmaKon, Fenner, Efson and Interrroll Corp.
Daniel Marks is the firm’s vice president of corporate development. He has worked at several other technology and medical services firms.
Jeffrey Bagshaw is senior vice president for sales. He has worked for Hoffman La Roche, Bristol Myers Squibb and Exact Sciences.
The company has also added several new sales personnel.
Inclinix, which was launched in 1999, also offers medical marketing communications and adherence services.
CRO Inclinix Names 3 Executives, Adds Sales Staff
Copyright 2008 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Jul. 3, 2009 - As Nortel’s final demise nears, what blame should its board shoulder?
Jul. 3, 2009 - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Jul. 3, 2009 - 20/20: Surgery can let you see like a child again
Jul. 3, 2009 |
- CDC: US swine flu cases rise to nearly 34,000
Jul. 3, 2009
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement


